Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity
Biomolecules · 2024
DOI: 10.3390/biom14111451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Dániel Molnár und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary. Hauptthemen laut MEDLINE: Clofazimine, Diarylquinolines, Linezolid, Antitubercular Agents. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Office for Research and Technology, Hungary.
Abstract (Originalsprache)
Tuberculosis (TB) presents significant medical challenges, largely due to the genetic diversity of Mycobacterium tuberculosis, which enhances the resilience and resistance of the pathogen to first-line treatments. In response to the global rise of drug-resistant TB, second-line antitubercular drugs like bedaquiline (BDQ), linezolid (LZD), and clofazimine (CFZ) have become critical treatment options. Understanding the molecular changes these drugs induce is essential for optimizing TB therapy. To contribute to this effort, we investigated their impact on genome maintenance and stability using Mycobacterium smegmatis as a model organism. Using mutation accumulation assays and whole-genome sequencing, we found that the second-line antibiotics did not significantly increase mutation rates, unlike the positive control UV treatment. However, upon BDQ treatment, we detected mutations in transporter proteins and transcription factors without any increase in the minimal inhibitory concentration. Additionally, BDQ and CFZ were found to alter DNA repair pathways and reduce cellular dNTP levels, particularly CFZ, which depleted dGTP, impacting DNA synthesis. CFZ also upregulated DNA repair enzymes, enhancing error-free repairs. Despite minimal mutagenic effects, both drugs displayed distinct impacts on cellular mechanisms, suggesting additional modes of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary.
- Doctoral School of Biology and Institute of Biology, ELTE Eötvös Loránd University, 1117 Budapest, Hungary.
ORCID-Profile: Dániel Molnár, Éva Viola Surányi, Judit Tóth, Rita Hirmondó
Förderung
- National Office for Research and Technology, Hungary
Zitieren
APA
Molnár, D., Surányi, É. V., Gálik, N., Tóth, J., & Hirmondó, R. (2024). Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity. Biomolecules. https://doi.org/10.3390/biom14111451
Vancouver
Molnár D, Surányi ÉV, Gálik N, Tóth J, Hirmondó R. Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity. Biomolecules. 2024. doi:10.3390/biom14111451
BibTeX
@article{Molnr2024,
author = {Molnár, Dániel and Surányi, Éva Viola and Gálik, Nikoletta and Tóth, Judit and Hirmondó, Rita},
title = {Assessing the Impact of Bedaquiline, Clofazimine, and Linezolid on Mycobacterial Genome Integrity},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14111451}
}
EUVIMED